mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
0.16 |
0.005 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
pac-1 |
GDSC1000 |
pan-cancer |
AAC |
0.099 |
0.005 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.006 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.006 |
mRNA |
CR-1-31B |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.007 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.007 |
mRNA |
CUDC-101 |
GDSC1000 |
pan-cancer |
AAC |
0.081 |
0.007 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.008 |
mRNA |
gossypol |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.008 |